Loestrin 24 Fe News
The Maybach Journal: Has added Warner Chilcott Ltd. to their watch ... - Trading Markets (press release)
Total revenues for 2008 are expected to be in the range of $935 to $945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, FEMCON FE, ...
Warner Chilcott initiated with "sector perform" - newratings.com
... is poised to post impressive revenue growth of 18% for 2007, aided by the successful 2006 product launches of Taclonex, Loestrin 24-Fe and Femcon-Fe. ...
Warner Chilcott Swings to 3Q Profit - CNNMoney.com
The revenue boost during the quarter was due mostly to sales of the contraceptive Loestrin 24 FE and the psoriasis treatment Taclonex, the company said. ...
Weak greenback helps US mid-cap firms - National Post
Two recent launches -- Loestrin 24 Fe, an oral contraceptive, and Taclonex for psoriasis -- are "important growth drivers with the potential to become ...
Local Business Briefs - 10/30 - Press-Enterprise
The company filed a patent infringement suit against Watson in August 2006 for attempting to market a generic version of the company's Loestrin 24 Fe ...
Weak greenback helps US mid-cap firms - Canada.com
Two recent launches -- Loestrin 24 Fe, an oral contraceptive, and Taclonex for psoriasis -- are "important growth drivers with the potential to become ...
Warner Chilcott "outperform," target price raised - newratings.com
Warner Chilcott’s Loestrin 24 Fe and Taclonex products posted robust revenues for the quarter, the analysts say. The company has raised its EPS guidance for ...
ZEOX Appoints Tim Wuest To Board - RTT News
Warner Chilcott attributed the strong results mainly to the net sales of two products introduced in March 2006, LOESTRIN 24 FE and TACLONEX, which together ...
Warner Chilcott Turns To Profit In Q2 On Higher Product Sales ... - RTT News
Warner Chilcott attributed the strong results mainly to the net sales of two products introduced in March 2006, LOESTRIN 24 FE and TACLONEX, which together ...
Warner Chilcott "outperform," target price raised - newratings.com
Warner Chilcott’s Loestrin 24 Fe and Taclonex products posted robust revenues for the quarter, the analysts say. The company has raised its EPS guidance for ...
Loestrin 24 Fe RSS Feed